Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

ישראלמגייס משתתפיםPHASE1, PHASE2

מצבים רפואיים

B-cell Acute Lymphoblastic Leukemia · Diffuse Large B-cell Lymphoma · Burkitt Lymphoma · Neuroblastoma · Ewing Sarcoma

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Children's Hospital Los Angeles ( Site 1006), Los Angeles, California, United States

    Study coordinator · 323-361-2121
  • Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora, Colorado, United States

    Study coordinator · 720-777-1234
  • Yale New Haven Hospital ( Site 1012), New Haven, Connecticut, United States

    Study coordinator · 203-785-4640
  • Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg, Florida, United States

    Study coordinator · 727-767-4176
  • University of Iowa-Holden Comprehensive Cancer Center ( Site 1017), Iowa City, Iowa, United States

    Study coordinator · 319-356-2296
  • Dana-Farber Cancer Institute ( Site 1013), Boston, Massachusetts, United States

    Study coordinator · 617-632-4580
  • Corewell Health ( Site 1001), Grand Rapids, Michigan, United States

    Study coordinator · 616-486-0746
  • Children's Mercy Hospital ( Site 1024), Kansas City, Missouri, United States

    Study coordinator · 816-302-6808
  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick, New Jersey, United States

    Study coordinator · 732-235-2465
  • Memorial Sloan Kettering Cancer Center ( Site 1010), New York, New York, United States

    Study coordinator · 888-492-8401
  • New York Medical College ( Site 1023), Valhalla, New York, United States

    Study coordinator · 914-614-4270
  • Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo, North Dakota, United States

    Study coordinator · 701-234-2000
  • Oregon Health and Science University ( Site 1004), Portland, Oregon, United States

    Study coordinator · 503-494-8311
  • Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia, Pennsylvania, United States

    Study coordinator · 267-425-5544
  • Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls, South Dakota, United States

    Study coordinator · 605-312-1000
  • University of Texas MD Anderson Cancer Center ( Site 1007), Houston, Texas, United States

    Study coordinator · 713-792-5410
  • Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City, Utah, United States

    Study coordinator · 801-662-4700
  • Sydney Children's Hospital ( Site 1997), Randwick, New South Wales, Australia

    Study coordinator · 61293821111
  • Queensland Children's Hospital-Oncology & Haematology ( Site 1996), Brisbane, Queensland, Australia

    Study coordinator · 61730681111
  • Royal Children's Hospital-Children's Cancer Centre ( Site 1994), Melbourne, Victoria, Australia

    Study coordinator · 61393455522
  • UZ Gent ( Site 1428), Ghent, Oost-Vlaanderen, Belgium

    Study coordinator · +3293320295
  • Hospital Erasto Gaertner-CEPEP - Pesquisa Clínica ( Site 1268), Curitiba, Paraná, Brazil

  • Hospital de Clinicas de Porto Alegre ( Site 1265), Porto Alegre, Rio Grande do Sul, Brazil

    Study coordinator · +5551980139616
  • Fundação Pio XII - Hospital de Câncer de Barretos ( Site 1264), Barretos, São Paulo, Brazil

    Study coordinator · +551733216638
  • Fundação Faculdade Regional de Medicina de São José do Rio Preto-Centro Integrado de Pesquisa ( Site 1267), São José do Rio Preto, São Paulo, Brazil

    Study coordinator · +55 17 3201-5054
  • The Hospital for Sick Children ( Site 1225), Toronto, Ontario, Canada

    Study coordinator · 416-813-1500
  • McGill University Health Centre-Pediatric HematologyOncology ( Site 1223), Montreal, Quebec, Canada

    Study coordinator · 514-412-4445
  • Hospital Clínico Regional Dr. Guillermo Grant Benavente ( Site 1881), Concepción, Biobio, Chile

    Study coordinator · +56994992198
  • Hospital Luis Calvo Mackenna ( Site 1879), Santiago, Region M. de Santiago, Chile

    Study coordinator · +56994992198
  • Hospital Carlos Van Buren ( Site 1880), Valparaíso, Valparaiso, Chile

    Study coordinator · 56978546125
  • Hospital Pablo Tobon Uribe ( Site 1923), Medellín, Antioquia, Colombia

    Study coordinator · +57 3006523572
  • Clinica de la Costa S.A.S.-Clinical Research Oncology & Hematology -Pediatric ( Site 1924), Barranquilla, Atlántico, Colombia

    Study coordinator · +573008096054
  • IMAT S.A.S ( Site 1921), Montería, Departamento de Córdoba, Colombia

    Study coordinator · 57317 3727618
  • Detska nemocnice FN Brno ( Site 1388), Brno, Brno-mesto, Czechia

    Study coordinator · +420532234755
  • Fakultni nemocnice v Motole-Klinika detske hematologie a onkologie ( Site 1387), Prague, Praha 5, Czechia

    Study coordinator · +420224436475
  • Rigshospitalet-Department of paediatrics and adolescent medicine, Section of Paed haem-onc ( Site 1467), Copenhagen, Capital Region, Denmark

    Study coordinator · +4535452462
  • CHU de Bordeaux. Hopital Pellegrin ( Site 1105), Bordeaux, Aquitaine, France

    Study coordinator · +33556795679
  • CENTRE LEON BERARD-IHOPE (pediatrric oncology) ( Site 1100), Lyon, Auvergne-Rhône-Alpes, France

    Study coordinator · 33469166572
  • Centre Hospitalier Universitaire de Nantes - Hôpital Femme-Enfant-Adolescent Chu De Nantes ( Site 1104), Nantes, Loire-Atlantique, France

    Study coordinator · 33240083610
  • Assistance Publique Hôpitaux de Marseille - Hôpital de la Timone ( Site 1102), Marseille, Provence-Alpes-Côte d'Azur Region, France

    Study coordinator · 33491386821
  • Gustave Roussy ( Site 1103), Villejuif, Île-de-France Region, France

    Study coordinator · +33142114211
  • Universitaetsklinikum Tuebingen ( Site 1142), Tübingen, Baden-Wurttemberg, Germany

    Study coordinator · +4970712983781
  • Universitaetsklinikum Koeln. Klinik und Poliklinik ( Site 1145), Cologne, North Rhine-Westphalia, Germany

    Study coordinator · 0049221 478 6831
  • Universitätsklinikum Münster - Albert Schweitzer Campus-Pädiatrische Hämatologie und Onkologie ( Site 1141), Münster, North Rhine-Westphalia, Germany

    Study coordinator · +492518347742
  • Charité Campus Virchow-Klinikum-Klinik für Pädiatrie mit Schwerpunkt Hämatologie und Onkologie ( Site 1143), Berlin, Germany

    Study coordinator · +4930 45050
  • Aghia Sophia Children's Hospital-First Department of Pediatrics, National and Kapodistrian Universi ( Site 1797), Athens, Attica, Greece

    Study coordinator · +302107452125
  • Semmelweis Egyetem ( Site 1838), Budapest, Hungary

    Study coordinator · +3612151380
  • Rambam Health Care Campus-Pediatric Hemato-Oncology ( Site 1674), Haifa, Israel

    Study coordinator · 97247774718
  • Sheba Medical Center ( Site 1675), Ramat Gan, Israel

    Study coordinator · +97235302996
  • Fondazione IRCCS Istituto Nazionale dei Tumori-Pediatric Oncology ( Site 1552), Milan, Lombardy, Italy

    Study coordinator · 00390223902593
  • Ospedale Pediatrico Bambino Gesù IRCCS-Dipartimento di Onco-Ematologia e Terapia Cellulare e Genica ( Site 1553), Rome, Roma, Italy

    Study coordinator · +39 06 68592377
  • Ospedale Infantile Regina Margherita-S.C. Oncoematologia Pediatrica ( Site 1551), Torino, Italy

    Study coordinator · 00390113135230
  • Prinses Maxima Centrum voor Kinderoncologie ( Site 1510), Utrecht, Netherlands

    Study coordinator · +31889729529
  • Narodny ustav detskych chorob ( Site 1592), Bratislava, Bratislava Region, Slovakia

    Study coordinator · +421259371205
  • Seoul National University Hospital-Pediatrics ( Site 1972), Seoul, South Korea

    Study coordinator · +82220723304
  • Asan Medical Center-Pediatrics - Pedicatric Oncology ( Site 1973), Seoul, South Korea

    Study coordinator · +82230105994
  • Hospital Sant Joan de Déu-Pediatric Oncology Department ( Site 1717), Esplugas de Llobregat, Barcelona, Spain

    Study coordinator · 34 93.600.97.33
  • Hospital Infantil Universitario Niño Jesús-Servicio de Onco-Hematología Pediátrica ( Site 1715), Madrid, Madrid, Comunidad de, Spain

    Study coordinator · +34913875000
  • Hospital Universitari Vall d'Hebron-Servei de Hematologia i Oncologia Pediatrica ( Site 1716), Barcelona, Spain

    Study coordinator · 34934893093
  • Sahlgrenska Universitetssjukhuset ( Site 1634), Gothenburg, Västra Götaland County, Sweden

    Study coordinator · +46313436655
  • National Taiwan University Hospital ( Site 1983), Taipei, Taiwan

    Study coordinator · 8862-23123456#70559
  • Ege Universitesi Hastanesi ( Site 1963), Bornova, İzmir, Turkey (Türkiye)

    Study coordinator · +90 232 390 43 87
  • Hacettepe Universite Hastaneleri ( Site 1961), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 305 50 00
  • Ankara Bilkent Şehir Hastanesi ( Site 1962), Ankara, Turkey (Türkiye)

    Study coordinator · +90 312 552 60 00
  • Birmingham Children's Hospital-Oncology/Haematology ( Site 1349), Birmingham, England, United Kingdom

    Study coordinator · +441213338233
  • Royal Victoria Infirmary-Great North Children's Hospital ( Site 1348), Newcastle upon Tyne, England, United Kingdom

    Study coordinator · 0191 282 1014
  • University College London Hospital ( Site 1350), London, London, City of, United Kingdom

    Study coordinator · 02034472485
  • Royal Marsden Hospital (Sutton)-Drug Development Unit ( Site 1347), Sutton, Surrey, United Kingdom

    Study coordinator · 020 8642 6011
  • University Hospital of Wales ( Site 1346), Cardiff, United Kingdom

    Study coordinator · +4402921842107
מובילי המחקר
  • Medical Director

    Study Director

    Merck Sharp & Dohme LLC